Clinical Trials in Pathum Wan, Thailand
2 recruiting
Showing 1–9 of 9 trials
Recruiting
Phase 3
Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer
Gastric CancerGastroesophageal-junction Cancer
Daiichi Sankyo726 enrolled250 locationsNCT06731478
Recruiting
Phase 3
A Phase 3 Study to Evaluate Petosemtamab Plus Pembrolizumab vs Pembrolizumab in First-line Treatment of Head and Neck Cancer (LiGeR - HN1)
Head and Neck Squamous Cell Carcinoma
Merus B.V.500 enrolled185 locationsNCT06525220
Recruiting
Phase 3
C-Forward: Efficacy and Safety of BEM/RZR vs SOF/VEL in Subjects With Chronic HCV
Hepatitis CHepatitis C, ChronicHepatitis C Virus Infection+1 more
Atea Pharmaceuticals, Inc.880 enrolled89 locationsNCT07037277
Recruiting
Phase 3
Long-term Follow-up of Long-acting Cabotegravir (CAB LA) for PrEP (Pre-exposure Prophylaxis) in Participants at Risk of Acquiring HIV (Human Immunodeficiency Virus)
HIV Infections
ViiV Healthcare3,508 enrolled34 locationsNCT06134362
Recruiting
Not Applicable
Thai PainPREDICT Validation Study
Type 1 Diabetes Mellitus (T1DM)Type 2 Diabetes Mellitus (T2DM)Neuropathic Pain+3 more
Chulalongkorn University277 enrolled1 locationNCT07195045
Recruiting
Phase 1
RV630 - Approach to Control HIV With Immune Enhancement and Vaccination (ACHIEV
HIV InfectionsARTAcute HIV Infection+1 more
Henry M. Jackson Foundation for the Advancement of Military Medicine48 enrolled1 locationNCT06484335
Recruiting
Behavioral and Psychosocial Characteristics of Clients Accessing Services at IHRI
HIV
Institute of HIV Research and Innovation Foundation, Thailand300,000 enrolled1 locationNCT06741319
Recruiting
The South-East Asian Transgender Health Cohort
HIVHCVSTIs
Institute of HIV Research and Innovation Foundation, Thailand450 enrolled5 locationsNCT05454579
Recruiting
Investigating Neurocognitive Disorders Epidemiology
DementiaCognitive DeclineAlzheimer Disease
King Chulalongkorn Memorial Hospital990 enrolled1 locationNCT06375213